Filings under CVRX by Candev Resource Exploration, Inc. (CIK 0001382462) from Oct 4, 2007 to Jul 7, 2009 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Binkowski Brent | CHIEF OPERATING OFFICER | Buy(P) | 26K | $2.91 | $76K |
| Aug 12, 2026 | Binkowski Brent | CHIEF OPERATING OFFICER | Sell(S) | 1K | $2.55 | $3K |
| Jun 1, 2026 | Nielsen Kirk G. | Director | Grant(A) | 9K | — | $0 |
| Jun 1, 2026 | Nielsen Kirk G. | Director | Grant(A) | 11K | — | $0 |
| Jun 1, 2026 | Jain Mudit K. | Director | Grant(A) | 9K | — | $0 |
| Jun 1, 2026 | Jain Mudit K. | Director | Grant(A) | 11K | — | $0 |
| Jun 1, 2026 | Slattery Joseph P | Director | Grant(A) | 9K | — | $0 |
| Jun 1, 2026 | Slattery Joseph P | Director | Grant(A) | 11K | — | $0 |
| Jun 1, 2026 | Hill, Mitch C. | Director | Grant(A) | 9K | — | $0 |
| Jun 1, 2026 | Hill, Mitch C. | Director | Grant(A) | 11K | — | $0 |
| Jun 1, 2026 | Ballinger Kevin J. | Director | Grant(A) | 9K | — | $0 |
| Jun 1, 2026 | Ballinger Kevin J. | Director | Grant(A) | 11K | — | $0 |
| Jun 1, 2026 | Shadan Martha | Director | Grant(A) | 9K | — | $0 |
| Jun 1, 2026 | Shadan Martha | Director | Grant(A) | 11K | — | $0 |
| Jun 1, 2026 | Dale Michael D | Director | Grant(A) | 29K | — | $0 |
| Jun 1, 2026 | Dale Michael D | Director | Grant(A) | 36K | — | $0 |
| Mar 2, 2026 | Morrison Gregory | CHIEF HUMAN RESOURCES OFFICER | Grant(A) | 34K | — | $0 |
| Mar 2, 2026 | Morrison Gregory | CHIEF HUMAN RESOURCES OFFICER | Grant(A) | 155K | — | $0 |
| Mar 2, 2026 | Hykes Kevin | PRES & CEO, Director | Sell(S) | 8K | $7.90 | $61K |
| Mar 2, 2026 | John Robert Allen | Chief Revenue Officer | Sell(S) | 4K | $7.90 | $31K |
| Mar 2, 2026 | Oasheim Jared | CHIEF FINANCIAL OFFICER | Sell(S) | 2K | $7.90 | $14K |
| Mar 2, 2026 | Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Sell(S) | 1K | $7.90 | $10K |
| Mar 2, 2026 | Adamson Philip B. | Chief Medical Officer | Sell(S) | 1K | $7.90 | $10K |
| Feb 27, 2026 | Hykes Kevin | PRES & CEO, Director | Grant(A) | 159K | — | $0 |
| Feb 27, 2026 | Hykes Kevin | PRES & CEO, Director | Grant(A) | 238K | — | $0 |
| Feb 27, 2026 | John Robert Allen | Chief Revenue Officer | Grant(A) | 35K | — | $0 |
| Feb 27, 2026 | John Robert Allen | Chief Revenue Officer | Grant(A) | 52K | — | $0 |
| Feb 27, 2026 | Binkowski Brent | CHIEF OPERATING OFFICER | Grant(A) | 15K | — | $0 |
| Feb 27, 2026 | Binkowski Brent | CHIEF OPERATING OFFICER | Grant(A) | 23K | — | $0 |
| Feb 27, 2026 | Oasheim Jared | CHIEF FINANCIAL OFFICER | Grant(A) | 61K | — | $0 |
| Feb 27, 2026 | Oasheim Jared | CHIEF FINANCIAL OFFICER | Grant(A) | 91K | — | $0 |
| Feb 27, 2026 | Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Grant(A) | 45K | — | $0 |
| Feb 27, 2026 | Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Grant(A) | 67K | — | $0 |
| Feb 27, 2026 | Adamson Philip B. | Chief Medical Officer | Grant(A) | 41K | — | $0 |
| Feb 27, 2026 | Adamson Philip B. | Chief Medical Officer | Grant(A) | 62K | — | $0 |
| Feb 20, 2026 | Jain Mudit K. | Director | Buy(P) | 47K | $6.36 | $298K |
| Feb 18, 2026 | Jain Mudit K. | Director | Buy(P) | 600 | $4.64 | $3K |
| Nov 26, 2025 | Johnson & Johnson | 10% Owner | Sell(S) | 6K | $10.03 | $64K |
| Nov 26, 2025 | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Sell(S) | 6K | $10.03 | $64K |
| Nov 25, 2025 | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Sell(S) | 16K | $10.03 | $160K |
| Nov 24, 2025 | Johnson & Johnson | 10% Owner | Sell(S) | 2K | $10.06 | $22K |
| Nov 21, 2025 | Johnson & Johnson | 10% Owner | Sell(S) | 500 | $10.00 | $5K |
| Nov 12, 2025 | Johnson & Johnson | 10% Owner | Sell(S) | 1K | $10.00 | $10K |
| Nov 7, 2025 | Johnson & Johnson | 10% Owner | Sell(S) | 200 | $10.00 | $2K |
| Nov 6, 2025 | Johnson & Johnson | 10% Owner | Sell(S) | 52K | $10.21 | $534K |
| Aug 11, 2025 | Binkowski Brent | CHIEF OPERATING OFFICER | Grant(A) | 17K | — | $0 |
| Aug 11, 2025 | Binkowski Brent | CHIEF OPERATING OFFICER | Grant(A) | 75K | — | $0 |
| Jun 3, 2025 | Shadan Martha | Director | Grant(A) | 20K | — | $0 |
| Jun 3, 2025 | Ballinger Kevin J. | Director | Grant(A) | 20K | — | $0 |
| Jun 3, 2025 | Hill, Mitch C. | Director | Grant(A) | 20K | — | $0 |
| Jun 3, 2025 | Slattery Joseph P | Director | Grant(A) | 20K | — | $0 |
| Jun 3, 2025 | Jain Mudit K. | Director | Grant(A) | 20K | — | $0 |
| Jun 3, 2025 | Nielsen Kirk G. | Director | Grant(A) | 20K | — | $0 |
| May 15, 2025 | Nielsen Kirk G. | Director | Buy(P) | 11K | $5.45 | $60K |
| May 14, 2025 | Nielsen Kirk G. | Director | Buy(P) | 61K | $5.23 | $320K |
| May 13, 2025 | Nielsen Kirk G. | Director | Buy(P) | 101K | $5.29 | $536K |
| May 13, 2025 | Jain Mudit K. | Director | Buy(P) | 150 | $5.26 | $789 |
| May 12, 2025 | Nielsen Kirk G. | Director | Buy(P) | 25K | $4.79 | $121K |
| May 12, 2025 | Hykes Kevin | PRES & CEO, Director | Buy(P) | 5K | $4.84 | $24K |
| May 12, 2025 | Jain Mudit K. | Director | Buy(P) | 2K | $4.66 | $7K |
| Feb 28, 2025 | Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Grant(A) | 16K | — | $0 |
| Feb 28, 2025 | Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Grant(A) | 24K | — | $0 |
| Feb 28, 2025 | Adamson Philip B. | Chief Medical Officer | Grant(A) | 20K | — | $0 |
| Feb 28, 2025 | Adamson Philip B. | Chief Medical Officer | Grant(A) | 30K | — | $0 |
| Feb 28, 2025 | Oasheim Jared | CHIEF FINANCIAL OFFICER | Grant(A) | 22K | — | $0 |
| Feb 28, 2025 | Oasheim Jared | CHIEF FINANCIAL OFFICER | Grant(A) | 33K | — | $0 |
| Feb 28, 2025 | John Robert Allen | Chief Revenue Officer | Grant(A) | 55K | — | $0 |
| Feb 28, 2025 | John Robert Allen | Chief Revenue Officer | Grant(A) | 38K | — | $0 |
| Feb 28, 2025 | Hykes Kevin | PRES & CEO, Director | Grant(A) | 98K | — | $0 |
| Feb 28, 2025 | Hykes Kevin | PRES & CEO, Director | Grant(A) | 148K | — | $0 |
| Nov 21, 2024 | Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Gift(G) | 1K | — | $0 |
| Nov 19, 2024 | Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Sell(S) | 1K | $13.58 | $19K |
| Nov 19, 2024 | Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Option exercise(M) | 3K | $5.14 | $13K |
| Nov 19, 2024 | Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Option exercise(M) | 3K | — | $0 |
| Sep 3, 2024 | Hill, Mitch C. | Director | Grant(A) | 36K | — | $0 |
| Sep 3, 2024 | Ballinger Kevin J. | Director | Grant(A) | 36K | — | $0 |
| Aug 15, 2024 | Slattery Joseph P | Director | Buy(P) | 3K | $8.10 | $24K |
| Aug 8, 2024 | Slattery Joseph P | Director | Buy(P) | 3K | $8.24 | $25K |
| Aug 6, 2024 | Slattery Joseph P | Director | Buy(P) | 3K | $9.09 | $23K |
| Aug 5, 2024 | Hykes Kevin | PRES & CEO, Director | Buy(P) | 30K | $8.36 | $251K |
| Jul 31, 2024 | Hykes Kevin | PRES & CEO, Director | Grant(A) | 180K | — | $0 |
| Jun 27, 2024 | John Robert Allen | Chief Revenue Officer | Grant(A) | 122K | — | $0 |
| Jun 4, 2024 | Behbahani Ali | Director | Grant(A) | 27K | — | $0 |
| Jun 4, 2024 | Shadan Martha | Director | Grant(A) | 27K | — | $0 |
| Jun 4, 2024 | Jain Mudit K. | Director | Grant(A) | 27K | — | $0 |
| Jun 4, 2024 | Slattery Joseph P | Director | Grant(A) | 27K | — | $0 |
| Jun 4, 2024 | Nielsen Kirk G. | Director | Grant(A) | 27K | — | $0 |
| Mar 25, 2024 | Palmer Craig E. | SVP, U.S. SALES | Option exercise(M) | 151 | $0.24 | $36 |
| Mar 25, 2024 | Palmer Craig E. | SVP, U.S. SALES | Option exercise(M) | 404 | $0.24 | $97 |
| Mar 25, 2024 | Palmer Craig E. | SVP, U.S. SALES | Option exercise(M) | 379 | $0.24 | $91 |
| Mar 25, 2024 | Palmer Craig E. | SVP, U.S. SALES | Option exercise(M) | 379 | — | $0 |
| Mar 25, 2024 | Palmer Craig E. | SVP, U.S. SALES | Option exercise(M) | 151 | — | $0 |
| Mar 25, 2024 | Palmer Craig E. | SVP, U.S. SALES | Option exercise(M) | 404 | — | $0 |
| Feb 29, 2024 | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Option exercise(M) | 142 | $1.19 | $169 |
| Feb 29, 2024 | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Option exercise(M) | 252 | $3.96 | $998 |
| Feb 29, 2024 | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Option exercise(M) | 442 | $1.19 | $526 |
| Feb 29, 2024 | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Option exercise(M) | 300 | $0.24 | $72 |
| Feb 29, 2024 | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Option exercise(M) | 584 | $0.24 | $140 |
| Feb 29, 2024 | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Option exercise(M) | 489 | $0.24 | $117 |
| Feb 29, 2024 | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Option exercise(M) | 758 | $0.24 | $182 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: CVRx, Inc., SEC CIK 0001235912. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under CVRX and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for CVRX